ascopubs.org

Efficacy and safety of XNW27011, a Claudin 18.2 targeting antibody drug conjugate with topoisomerase 1 inhibitor payload, in patients with Claudin 18.2 positive gastric ...

First-in-human study of BG-C9074, a B7-H4-targeting ADC in patients with advanced solid tumors: Preliminary results of the dose-escalation phase.
ascopubs.org

Exatecan (DX-8951f), a new topoisomerase I - inhibitor, is inactive in heavily pretreated patients (pts.) with advanced soft tissue sarcoma (STS): A phase II - study of the ...

Hormonal treatment of endometrial stromal sarcomas (ESS): A possible indication for aromatase inhibitors No standard treatment is established for patients with advanced soft tissue sarcoma after ...